Authors/Disclosures
|
John A. Lincoln, MD, PhD
(McGovern Medical School, UTHealth)
|
The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care. |
|
George Shokri, MD
|
No disclosure on file |
|
Antonio Belenguer
(Hospital General Castellon)
|
No disclosure on file |
|
Yelena Vidgop, MD
(Integrative Neurology Inc)
|
Dr. Vidgop has nothing to disclose. |
|
|
No disclosure on file |
|
Diego Cadavid, MD, FAAN
(Verge Genomics)
|
Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has stock in Verge Genomics. |
|
Leo Wolansky, MD
|
The institution of Dr. Wolansky has received research support from Guerbet. |
|
|
No disclosure on file |
|
Stuart D. Cook, MD, FAAN
(Rutgers)
|
No disclosure on file |